GdVO4:Eu3+,Bi3+ Nanoparticles as a Contrast Agent for MRI and Luminescence Bioimaging
Author(s) -
Guannan Zhu,
Liping Chen,
Fanxin Zeng,
Lei Gu,
XueFeng Yu,
Xue Li,
Jing Jiang,
Gang Guo,
Jiayi Cao,
Ke Tang,
Hongyan Zhu,
Heike E. DaldrupLink,
Min Wu
Publication year - 2019
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.9b00444
Subject(s) - luminescence , gadolinium , mri contrast agent , biocompatibility , vanadate , nanoparticle , magnetic resonance imaging , lanthanide , in vivo , materials science , persistent luminescence , imaging agent , nuclear magnetic resonance , chemistry , nanotechnology , ion , inorganic chemistry , optoelectronics , medicine , physics , microbiology and biotechnology , organic chemistry , thermoluminescence , biology , metallurgy , radiology
With the development of multifunctional imaging, gadolinium (Gd)-bearing inorganic nanoparticles (NPs), which were doped with trivalent lanthanide (Ln 3+ ), have been applied in magnetic resonance imaging (MRI) and optical imaging owing to their high payload of Gd 3+ ions and specific optical characteristics. In this study, we chose GdVO 4 codoped with Eu 3+ and Bi 3+ as the host material to generate a highly efficient contrast agent (CA) for MRI and long-term luminescence imaging. The new CA emits strong and stable luminescence because of its strong characteristic emissions, resulting from the energy-transfer process from the vanadate groups (VO 4 3- ) to the Eu 3+ and Bi 3+ dopants. Additionally, these NPs provided conspicuous T 1 and T 2 relaxation time-shortening characteristics, which result in MRI enhancement. GdVO 4 :Eu 3+ ,Bi 3+ NPs were tested on liver tumor-bearing nude mice, and showed improved liver tumor contrast in T 2 -weighted MR images ( T 2 WI). The dual-modal imaging probe exhibited no cytotoxicity or organ toxicity, reflecting its excellent biocompatibility. Thus, GdVO 4 :Eu 3+ ,Bi 3+ has the potential to be used for bioassays in vitro and liver tumor targeting in vivo . The results reveal the great promise of using the designed GdVO 4 :Eu 3+ ,Bi 3+ NPs as luminescent and MRI dual-mode bioprobes for clinical bioimaging applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom